
$13.5 Million Eli Lilly Settlement Includes Four-Year Cap on Insulin Prices
Eli Lilly & Co. has agreed to pay $13.5 million and cap the price of insulin for four years to settle long-running class action litigation that alleged the pharma company illegally colluded to drive up the price of the life-saving diabetes medication.